Transcriptomics

Dataset Information

0

Genomic predictors of response to doxorubicin versus docetaxel in breast cancer


ABSTRACT: Low topo2a expression and ER-negative status were predictors of response to doxorubicin, while small tumor size and ER-negative status predicted response to docetaxel. Docetaxel was superior to doxorubicin in triple-negative/basal-like tumors, while no significant differences between these drugs were seen in the remaining intrinsic subtypes Keywords: reference x sample reference x sample

ORGANISM(S): Homo sapiens  

SUBMITTER: Charles Perou  Charles M Perou   M M Martin    

PROVIDER: E-GEOD-21997 | ArrayExpress | 2011-05-27

SECONDARY ACCESSION(S): GSE21997PRJNA127219

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets

2011-03-18 | E-GEOD-22358 | ArrayExpress
2009-01-18 | E-GEOD-11429 | ArrayExpress
2010-01-06 | E-GEOD-16113 | ArrayExpress
2010-05-08 | E-GEOD-15948 | ArrayExpress
2008-06-18 | E-GEOD-8516 | ArrayExpress
2012-01-13 | E-GEOD-22226 | ArrayExpress
2012-07-13 | E-GEOD-23428 | ArrayExpress
2014-08-20 | E-GEOD-51783 | ArrayExpress
2008-06-16 | E-GEOD-9343 | ArrayExpress
2013-06-25 | E-GEOD-34412 | ArrayExpress